Abstract:N6-methyladenosine (m6A) is one of the most common internal modifications in eukaryotic RNA. The presence of m6A on transcripts can affect a series of fundamental cellular processes, including mRNA splicing, nuclear transportation, stability, and translation. The m6A modification is introduced by m6A methyltransferases (writers), removed by demethylases (erasers), and recognized by m6A-binding proteins (readers). Current research has demonstrated that m6A methylation is involved in the regulation of malignant phenotypes in tumors by controlling the expression of cancer-related genes. Non-coding RNAs (ncRNAs) are a diverse group of RNA molecules that do not encode proteins and are widely present in the human genome. This group includes microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and PIWI interaction RNAs (piRNAs). They function as oncogenes or tumor suppressors through various mechanisms, regulating the initiation and progression of cancer. Previous studies on m6A primarily focused on coding RNAs, but recent discoveries have revealed the significant regulatory role of m6A in ncRNAs. Simultaneously, ncRNAs also exert their influence by modulating the stability, splicing, translation, and other biological processes of m6A-related enzymes. The interplay between m6A and ncRNAs collectively contributes to the occurrence and progression of malignant tumors in humans. This review provides an overview of the interactions between m6A regulatory factors and ncRNAs and their impact on tumors.

Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells

The emerging roles of N6-methyladenosine RNA methylation in human cancers

The interplay between m6A RNA methylation and noncoding RNA in cancer

Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer

N6-methyladenine modification in noncoding RNAs and its function in cancer

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.

Emerging roles of the crosstalk between non-coding RNAs and m<SUP>6</SUP>A modification in cancers

The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression

Dynamic M6a-Ncrnas Association and Their Impact on Cancer Pathogenesis, Immune Regulation and Therapeutic Response

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

The Roles of M6a RNA Modifiers in Human Cancer

N6-methyladenosine Modification: an Important Player in the Tumor Immune Microenvironment.

N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer

New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification

Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment

The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing

Novel insights into the interplay between m 6 A modification and noncoding RNAs in cancer

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment

The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system

The Interaction Between N6-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers

N6-methyladenosine (m6a) RNA Modification in Tumor Immunity